UK partners with Pakistan to tackle the threat of antibiotic resistance
The UK has expanded its partnership with Pakistan to tackle the growing threat of antibiotic resistance in the country. The UK will invest more than £2.7 million in Pakistan to strengthen disease surveillance systems, improve laboratory infrastructure and offer six professional fellowships to senior scientists to build expertise.
The programme is led by the UK’s Department of Health and Social Care (DHSC), with Mott MacDonald contracted as the Management Agent of the fund, and Development Alternatives Inc (DAI) appointed as the lead project partner to deliver most of the investment in Pakistan.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.